Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.

Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW; Scientific Advisory Group; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2016 Feb;169:116-21.e2. doi: 10.1016/j.jpeds.2015.08.042. Epub 2015 Sep 19.

PMID:
26388208
2.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC; ESCF Investigators.

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.

3.

Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.

Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators; coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013. Epub 2013 Jun 27.

4.

Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis.

Schechter MS, McColley SA, Regelmann W, Millar SJ, Pasta DJ, Wagener JS, Konstan MW, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

J Pediatr. 2011 Nov;159(5):819-824.e1. doi: 10.1016/j.jpeds.2011.05.005. Epub 2011 Jun 25.

5.

Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.

Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis; North American Scientific Advisory Group for ESCF.

J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059. Epub 2009 Jul 16.

6.

Use of bilevel positive airway pressure (BIPAP) in end-stage patients with cystic fibrosis awaiting lung transplantation.

Caronia CG, Silver P, Nimkoff L, Gorvoy J, Quinn C, Sagy M.

Clin Pediatr (Phila). 1998 Sep;37(9):555-9.

PMID:
9773239
7.

Clinical spectrum in homozygotes and compound heterozygotes inheriting cystic fibrosis mutation 3849 + 10kbC > T: significance for geneticists.

Gilbert F, Li Z, Arzimanoglou II, Bialer M, Denning C, Gorvoy J, Honorof J, Ores C, Quittell L, Arzimanoglou I, et al.

Am J Med Genet. 1995 Sep 25;58(4):356-9. Erratum in: Am J Med Genet 1996 Aug 23;64(3):527.

PMID:
8533846
8.

A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.

Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittel L, Friedman KJ, Silverman LM, et al.

N Engl J Med. 1994 Oct 13;331(15):974-80.

9.

Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.

Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD.

J Pediatr. 1994 Oct;125(4):587-9.

PMID:
7931879
10.

Quantitative deposition of aerosolized gentamicin in cystic fibrosis.

Ilowite JS, Gorvoy JD, Smaldone GC.

Am Rev Respir Dis. 1987 Dec;136(6):1445-9.

PMID:
3688646
11.

Portal vein measurement by ultrasonography in patients with long-standing cystic fibrosis: preliminary observations.

Kumari-Subaiya S, Gorvoy J, Phillips G, Ross P, Riddelsberger MM.

J Pediatr Gastroenterol Nutr. 1987 Jan-Feb;6(1):71-8.

PMID:
3540261
12.

Lack of aminoglycoside-induced nephrotoxicity in cystic fibrosis.

Schofield DH, Mangione RA, Kay BG, Gorvoy JD.

Drug Intell Clin Pharm. 1984 Feb;18(2):153-5. No abstract available.

PMID:
6697878
13.

Recurrent mucoid impaction in an asthmatic infant with cow's milk protein allergy.

Fruchter L, Gorvoy J, Abramson A, Wind E.

Ann Allergy. 1982 May;48(5):292-3. No abstract available.

PMID:
7081782
14.

Seropositive rheumatoid arthritis in a patient with cystic fibrosis.

Sagransky DM, Greenwald RA, Gorvoy JD.

Am J Dis Child. 1980 Mar;134(3):319-20. No abstract available.

PMID:
6767394
15.

Cystic fibrosis and hearing loss.

Forman-Franco B, Abramson AL, Gorvoy JD, Stein T.

Arch Otolaryngol. 1979 Jun;105(6):338-42.

PMID:
454286
16.

Endobronchial balloon tamponade of hemoptysis in patients with cystic fibrosis.

Swersky RB, Chang JB, Wisoff BG, Gorvoy J.

Ann Thorac Surg. 1979 Mar;27(3):262-4. No abstract available.

PMID:
378149
17.

Rheology of submaxillary secretions of cystic fibrosis patients and normal individuals.

Bettelheim FA, Epstein S, Gorvoy JD.

Biorheology. 1971 Dec;8(3):129-38. No abstract available.

PMID:
5146948
18.

Erythromycin propionate and potassium penicillin V in the treatment of group A stretpococcal pharyngitis.

STILLERMAN M, BERNSTEIN SH, SMITH M, GORVOY JD.

Pediatrics. 1963 Jan;31(1) Pt 1:22-8. No abstract available.

PMID:
13984168
19.

Unilateral renal agenesis in two siblings. Case report.

GORVOY JD, SMULEWICZ J, ROTHFELD SH.

Pediatrics. 1962 Feb;29:270-3. No abstract available.

PMID:
13900618
20.

The hazard of induction of sweating in cystic fibrosis of the pancreas.

GORVOY JD, ACS H, STEIN ML.

Pediatrics. 1960 Jun;25:977-82. No abstract available.

PMID:
13851354
Items per page

Supplemental Content

Loading ...
Write to the Help Desk